<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40470798</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Incidence and Risk Factors for Venous Thromboembolism Events After Rectal Prolapse Surgery.</ArticleTitle><Pagination><StartPage>1215</StartPage><EndPage>1223</EndPage><MedlinePgn>1215-1223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003838</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The most common cause of preventable death in hospitalized patients in the United States is venous thromboembolism. Although pelvic organ prolapse surgery in urogynecology literature reports rates less than 1%, the rate of venous thromboembolism for rectal prolapse surgery remains undescribed. We hypothesized that the rate of venous thromboembolism with rectal prolapse surgery would be low and that risk factors would include surgical approach, BMI, longer operative time, older age, renal failure, and functional status.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Define the incidence and identify risk factors associated with venous thromboembolism events in the 30-day postoperative period after rectal prolapse surgery.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">A retrospective analysis of the American College of Surgeons-National Surgical Quality Improvement Program between 2005 and 2021.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Patients with Current Procedural Terminology codes to identify rectal prolapse procedures.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Incidence of venous thromboembolism and risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19,197 rectal prolapse procedures were analyzed. Overall, 61 patients (0.32%) developed venous thromboembolism within 30 days of surgery. More than 60% (37) of the venous thromboemboli developed within 2 weeks of the operation. On multivariable analysis, dependent functional status was an independent risk factor for venous thromboembolism after surgery for rectal prolapse (OR 2.62 [1.31-4.87]), and longer length of stay (OR 1.048 [1.028-1.65]), postoperative surgical site infections (OR 3.59 [1.61-7.17]), and bleeding (OR 4.35 [1.864-8.92]) were associated with venous thromboembolism.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Unable to assess perioperative chemoprophylaxis use.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall incidence of venous thromboembolism after rectal prolapse repair is very low, similar to that reported in the literature examining venous thromboembolism after pelvic organ prolapse repair. Most venous thromboembolic events occurred within the first 2 weeks of surgery. Preoperative dependent functional status, postoperative bleeding, and surgical site infection were identified as independent risk factors for venous thromboembolism. See Video Abstract.</AbstractText><AbstractText Label="INCIDENCIA Y FACTORES DE RIESGO DE EVENTOS TROMBOEMBLICOS VENOSOS TRAS CIRUGA DE PROLAPSO RECTAL" NlmCategory="UNASSIGNED">ANTECEDENTES:La causa m&#xe1;s com&#xfa;n de muerte evitable en pacientes hospitalizados en los Estados Unidos es la tromboembolia venosa. Si bien la literatura sobre uroginecolog&#xed;a indica que la tasa de prolapso de &#xf3;rganos p&#xe9;lvicos es &lt;1 %, la tasa de tromboembolia venosa en la cirug&#xed;a de prolapso rectal sigue sin describirse. Nuestra hip&#xf3;tesis era que la tasa de tromboembolia venosa en la cirug&#xed;a de prolapso rectal ser&#xed;a baja y que los factores de riesgo incluir&#xed;an el abordaje quir&#xfa;rgico, el &#xed;ndice de masa corporal, el tiempo quir&#xfa;rgico m&#xe1;s prolongado, la edad avanzada, la insuficiencia renal y el estado funcional.OBJETIVO:Definir la incidencia e identificar los factores de riesgo asociados a los eventos de tromboembolia venosa en el periodo postoperatorio de 30 d&#xed;as tras la cirug&#xed;a de prolapso rectal.FUENTES DE DATOS:An&#xe1;lisis retrospectivo del Programa Nacional de Mejora de la Calidad Quir&#xfa;rgica del Colegio Americano de Cirujanos entre 2005 y 2021.SELECCI&#xd3;N DEL ESTUDIO:Pacientes con c&#xf3;digos de terminolog&#xed;a procedimental actual para identificar procedimientos de prolapso rectal.PRINCIPALES MEDIDAS DE RESULTADO:Incidencia de tromboembolia venosa y factores de riesgo.RESULTADOS:Se analizaron un total de 19 197 procedimientos de prolapso rectal. En general, 61 (0,32 %) pacientes desarrollaron tromboembolia venosa en los 30 d&#xed;as posteriores a la cirug&#xed;a. M&#xe1;s del 60 % (37) de las tromboembolias venosas se desarrollaron en las dos semanas posteriores a la operaci&#xf3;n. En el an&#xe1;lisis multivariable, el estado funcional dependiente fue un factor de riesgo independiente de tromboembolia venosa tras la cirug&#xed;a de prolapso rectal (odds ratio 2,62 [1,31,4,87]) y una estancia hospitalaria m&#xe1;s prolongada (odds ratio 1,048 [1,028, 1,65]), las infecciones postoperatorias en el sitio quir&#xfa;rgico (odds ratio 3,59 [1,61, 7,17]) y el sangrado (odds ratio 4,35 [1,864, 8,92]) se asociaron con la tromboembolia venosa.LIMITACIONES:No se pudo evaluar el uso de quimioprofilaxis perioperatoria.CONCLUSIONES:La incidencia global de tromboembolia venosa tras la reparaci&#xf3;n del prolapso rectal es muy baja, similar a la descrita en la literatura que examina la tromboembolia venosa tras la reparaci&#xf3;n del prolapso de &#xf3;rganos p&#xe9;lvicos. La mayor&#xed;a de los eventos tromboemb&#xf3;licos venosos se produjeron en las dos primeras semanas tras la cirug&#xed;a. El estado funcional dependiente preoperatorio, el sangrado postoperatorio y la infecci&#xf3;n del sitio quir&#xfa;rgico se identificaron como factores de riesgo independientes de tromboembolia venosa. ( AI-generated translation ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jochum</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Colon and Rectal Surgery, Cleveland Clinic Foundation, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belkovsky</LastName><ForeName>Mikhael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kirschling</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Holubar</LastName><ForeName>Stefan D</ForeName><Initials>SD</Initials></Author><Author ValidYN="Y"><LastName>Hull</LastName><ForeName>Tracy L</ForeName><Initials>TL</Initials></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>David R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Spivak</LastName><ForeName>Anna R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Scott R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Ban</LastName><ForeName>Kristen A</ForeName><Initials>KA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012005" MajorTopicYN="Y">Rectal Prolapse</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Rectal prolapse</Keyword><Keyword MajorTopicYN="N">Venous thromboembolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>17</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40470798</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003838</ArticleId><ArticleId IdType="pii">00003453-990000000-00964</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e227S&#x2013;e277S.</Citation></Reference><Reference><Citation>Lee CHA, Jia X, Lipman JM, et al. Defining the economic burden of perioperative venous thromboembolism in inflammatory bowel disease in the United States. Dis Colon Rectum. 2021;64:871&#x2013;880.</Citation></Reference><Reference><Citation>Sutedjo JL, Ng RK, Piazza G, Goldhaber SZ. Medicare&#x2019;s new regulations for deep vein thrombosis as a &#x201c;never event&#x201d;: wise or worrisome? Am J Med. 2009;122:975&#x2013;976.</Citation></Reference><Reference><Citation>Chong W, Bui AH, Menhaji K. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs. Am J Obstet Gynecol. 2022;223:268.e1&#x2013;268.e26.</Citation></Reference><Reference><Citation>Bergqvist D, Agnelli G, Cohen AT, et al.; ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975&#x2013;980.</Citation></Reference><Reference><Citation>Wallaert JB, De Martino RR, Marsicovetere PS, et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum. 2012;55:1138&#x2013;1144.</Citation></Reference><Reference><Citation>Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119(suppl):132S&#x2013;175S.</Citation></Reference><Reference><Citation>Clement E, Dang J, Laffin M, Wang H. Incidence of venous thromboembolism following proctectomy is greater in ulcerative colitis than in malignancy or Crohn&#x2019;s disease. J Gastrointest Surg. 2020;24:2664&#x2013;2666.</Citation></Reference><Reference><Citation>Cohen ME, Ko CY, Bilimoria KY, et al. Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg. 2013;217:336&#x2013;346.</Citation></Reference><Reference><Citation>Hokenstad ED, Habermann EB, Glasgow AE, Occhino JA. Risk of venous thromboembolism in patients undergoing surgery for pelvic organ prolapse. Int Urogynecol J. 2016;27:1525&#x2013;1528.</Citation></Reference><Reference><Citation>McKechnie T, Wang J, Springer JE, Gross PL, Forbes S, Eskicioglu C. Extended thromboprophylaxis following colorectal surgery in patients with inflammatory bowel disease: a comprehensive systematic clinical review. Colorectal Dis. 2020;22:663&#x2013;678.</Citation></Reference><Reference><Citation>Jochum S, Steele S, Belkovsky M, et al. Incidence and risk factors for venous thromboembolism events after rectal prolapse surgery [ASCRS abstract QS211]. Dis Colon Rectum. 2024;67:e492&#x2013;e493.</Citation></Reference><Reference><Citation>Guven DC, Aksun MS, Sahin TK, et al. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy. Support Care Cancer. 2021;29:5417&#x2013;5423.</Citation></Reference><Reference><Citation>Farmakis IT, Barco S, Mavromanoli AC, Konstantinides SV, Valerio L. Performance status and long-term outcomes in cancer-associated pulmonary embolism: insights from the Hokusai-VTE Cancer Study. JACC Cardiooncol. 2022;4:507&#x2013;518.</Citation></Reference><Reference><Citation>Papadopoulos E, Abdulrehman J, Alibhai SMH. The value of performance status in predicting clinical outcomes in patients with cancer-associated pulmonary embolism. JACC Cardiooncol. 2022;4:519&#x2013;521.</Citation></Reference><Reference><Citation>Kunutsor SK, M&#xe4;kikallio TH, Seidu S, et al. Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. Eur J Epidemiol. 2020;35:431&#x2013;442.</Citation></Reference><Reference><Citation>Boden I, Skinner EH, Browning L, et al. Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ. 2018;360:j5916.</Citation></Reference><Reference><Citation>Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S&#x2013;e496S.</Citation></Reference><Reference><Citation>Ban KA, Gibbons MM, Ko CY, Wick EC. Surgical technical evidence review for colorectal surgery conducted for the AHRQ Safety Program for Improving Surgical Care and Recovery. J Am Coll Surg. 2017;225:548&#x2013;557.e3.</Citation></Reference><Reference><Citation>Lewis-Lloyd CA, Humes DJ, West J, Peacock O, Crooks CJ. The duraion and magnitude of postdischarge venous thromboembolism following colectomy. Ann Surg. 2022;276:e177&#x2013;e184.</Citation></Reference><Reference><Citation>Study Group ENOXACAN. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg. 1997;84:1099&#x2013;1103.</Citation></Reference><Reference><Citation>Laureano M, Ebraheem M, Crowther M. Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review. Curr Oncol. 2019;26:e106&#x2013;e110.</Citation></Reference><Reference><Citation>Chindamo MC, Marques MA. Bleeding risk assessment for venous thromboembolism prophylaxis. J Vasc Bras. 2021;20:e20200109.</Citation></Reference><Reference><Citation>Lutsey PL, Windham BG, Misialek JR, et al. Long-term association of venous thromboembolism with frailty, physical functioning, and quality of life: the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2020;9:e015656.</Citation></Reference><Reference><Citation>Monn MF, Hui X, Lau BD, et al. Infection and venous thromboembolism in patients undergoing colorectal surgery: what is the relationship? Dis Colon Rectum. 2014;57:497&#x2013;505.</Citation></Reference><Reference><Citation>Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129:290&#x2013;295.</Citation></Reference><Reference><Citation>Alikhan R, Spyropoulos AC. Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med. 2008;121:935&#x2013;942.</Citation></Reference><Reference><Citation>Monn MF, Haut ER, Lau BD, et al. Is venous thromboembolism in colorectal surgery patients preventable or inevitable? One institution&#x2019;s experience. J Am Coll Surg. 2013;216:395&#x2013;401.e1.</Citation></Reference><Reference><Citation>Magruder JT, Efron JE, Wick EC, Gearhart SL. Laparoscopic rectopexy for rectal prolapse to reduce surgical-site infections and length of stay. World J Surg. 2013;37:1110&#x2013;1114.</Citation></Reference><Reference><Citation>Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45:335&#x2013;341.</Citation></Reference><Reference><Citation>Moghadamyeghaneh Z, Alizadeh RF, Hanna MH, et al. Post-hospital discharge venous thromboembolism in colorectal surgery. World J Surg. 2016;40:1255&#x2013;1263.</Citation></Reference><Reference><Citation>Abeles A, Kwasnicki RM, Pettengell C, Murphy J, Darzi A. The relationship between physical activity and post-operative length of hospital stay: a systematic review. Int J Surg. 2017;44:295&#x2013;302.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40418694</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Outcomes After Elective Versus Emergency Resection for Right-Sided Colon Cancer: A Propensity Score-Matched Analysis.</ArticleTitle><Pagination><StartPage>753</StartPage><EndPage>763</EndPage><MedlinePgn>753-763</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003680</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous studies reported similar complication rates, including anastomotic leakage, after elective and emergency surgery for right-sided colon cancer. This led to the consensus that emergency resection with primary anastomosis is safe. However, recent evidence suggests higher complication rates after emergency surgery, indicating that alternative strategies, such as a bridge to surgery, may be more suitable.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess whether complication rates, particularly anastomotic leakage, are higher after emergency resections compared to elective resections in patients with right-sided colon cancer.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study using data from the Dutch ColoRectal Audit from 2010 to 2019.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Nationwide data from hospitals across the Netherlands.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients who underwent resection for right-sided colon cancer (n = 5056 emergency resections matched 1:1 to elective resections using propensity score matching).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Incidence of anastomotic leakage, 90-day complication rates, and mortality rates after elective versus emergency surgery for right-sided colon cancer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After matching, no significant baseline differences remained. There was no significant difference in anastomotic leakage rates. However, the mortality rate was twice as high in the emergency group (9.4% vs 4.2%, p &lt; 0.001), and the 90-day complication rate was also higher (41.7% vs 33.0%, p &lt; 0.001).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Minimal missing data were handled with multiple imputation. Although propensity score matching was used, bias from unknown confounders may persist. The emergency group included more high-risk patients, potentially influencing outcomes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Emergency resections for right-sided colon cancer are associated with higher complication and mortality rates compared to elective surgery. A bridge-to-surgery approach could reduce these risks by converting emergency cases to elective procedures. Further research is needed to validate these findings. See Video Abstract.</AbstractText><AbstractText Label="RESULTADOS TRAS LA RESECCIN ELECTIVA FRENTE A LA RESECCIN DE EMERGENCIA PARA CNCER DE COLON DEL LADO DERECHO UN ANLISIS DE PUNTUACIN DE PROPENSIN COINCIDENTE" NlmCategory="UNASSIGNED">ANTECEDENTES:Estudios previos informaron tasas de complicaciones similares, incluida la fuga anastom&#xf3;tica, despu&#xe9;s de una cirug&#xed;a electiva y de emergencia para el c&#xe1;ncer de colon del lado derecho. Esto llev&#xf3; al consenso de que la resecci&#xf3;n de emergencia con anastomosis primaria es segura. Sin embargo, evidencia reciente sugiere tasas de complicaciones m&#xe1;s altas despu&#xe9;s de la cirug&#xed;a de emergencia, lo que indica que las estrategias alternativas, como un puente a la cirug&#xed;a, pueden ser m&#xe1;s adecuadas.OBJETIVO:Evaluar si las tasas de complicaciones, en particular la fuga anastom&#xf3;tica, son m&#xe1;s altas despu&#xe9;s de las resecciones de emergencia en comparaci&#xf3;n con las resecciones electivas en pacientes con c&#xe1;ncer de colon del lado derecho.DISE&#xd1;O:Un estudio de cohorte retrospectivo que utiliza datos de la Dutch ColoRectal Audit de 2010 a 2019.ESCENARIO:Datos a nivel nacional de hospitales de los Pa&#xed;ses Bajos.PACIENTES:Pacientes que se sometieron a una resecci&#xf3;n por c&#xe1;ncer de colon del lado derecho (n = 5056 resecciones de emergencia emparejadas 1:1 con resecciones electivas mediante emparejamiento por puntaje de propensi&#xf3;n).PRINCIPALES MEDIDAS DE VALORACI&#xd3;N:Incidencia de fuga anastom&#xf3;tica, tasas de complicaciones a los 90 d&#xed;as y tasas de mortalidad despu&#xe9;s de cirug&#xed;a electiva versus cirug&#xed;a de emergencia para c&#xe1;ncer de colon del lado derecho.RESULTADOS:Despu&#xe9;s del emparejamiento, no se mantuvieron diferencias significativas al inicio. No hubo diferencias significativas en las tasas de fuga anastom&#xf3;tica. Sin embargo, la tasa de mortalidad fue dos veces m&#xe1;s alta en el grupo de emergencia (9,4% frente a 4,2%, p &lt; 0,001) y la tasa de complicaciones a los 90 d&#xed;as tambi&#xe9;n fue mayor (41,7% frente a 33,0%, p &lt; 0,001).LIMITACIONES:Los datos faltantes m&#xed;nimos se manejaron con imputaci&#xf3;n m&#xfa;ltiple. Si bien se utiliz&#xf3; el emparejamiento por puntaje de propensi&#xf3;n, puede persistir el sesgo de factores de confusi&#xf3;n desconocidos. El grupo de emergencia incluy&#xf3; m&#xe1;s pacientes de alto riesgo, lo que potencialmente influy&#xf3; en los resultados.CONCLUSIONES:Las resecciones de emergencia para c&#xe1;ncer de colon del lado derecho se asocian con mayores tasas de complicaciones y mortalidad en comparaci&#xf3;n con la cirug&#xed;a electiva. Un enfoque de puente a la cirugia podr&#xed;a reducir estos riesgos al convertir los casos de urgencia en procedimientos electivos. Se necesitan m&#xe1;s investigaciones para validar estos hallazgos. (Traducci&#xf3;n--Ingrid Melo).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kertzman</LastName><ForeName>Bas A J</ForeName><Initials>BAJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amelung</LastName><ForeName>Femke J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burghgraef</LastName><ForeName>Thijs A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Consten</LastName><ForeName>Esther C J</ForeName><Initials>ECJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Meander MC, Amersfoort, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Draaisma</LastName><ForeName>Werner A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="Y">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="Y">Anastomotic Leak</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004638" MajorTopicYN="Y">Emergency Treatment</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bridge to surgery</Keyword><Keyword MajorTopicYN="N">Elective resection</Keyword><Keyword MajorTopicYN="N">Emergency surgery</Keyword><Keyword MajorTopicYN="N">Propensity score matching</Keyword><Keyword MajorTopicYN="N">Right-sided colon cancer</Keyword><Keyword MajorTopicYN="N">Short-term outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40418694</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003680</ArticleId><ArticleId IdType="pii">00003453-202506000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg. 2018;13:36.</Citation></Reference><Reference><Citation>Smithers BM, Theile DE, Cohen JR, Evans EB, Davis NC. Emergency right hemicolectomy in colon carcinoma: a prospective study. Aust N Z J Surg. 1986;56:749&#x2013;752.</Citation></Reference><Reference><Citation>Veyrie N, Ata T, Muscari F, et al.; French Associations for Surgical Research. Anastomotic leakage after elective right versus left colectomy for cancer: prevalence and independent risk factors. J Am Coll Surg. 2007;205:785&#x2013;793.</Citation></Reference><Reference><Citation>Bakker IS, Grossmann I, Henneman D, Havenga K, Wiggers T. Risk factors for anastomotic leakage and leak-related mortality after colonic cancer surgery in a nationwide audit. Br J Surg. 2014;101:424&#x2013;432.</Citation></Reference><Reference><Citation>Teixeira Farinha H, Melloul E, Hahnloser D, Demartines N, H&#xfc;bner M. Emergency right colectomy: which strategy when primary anastomosis is not feasible? World J Emerg Surg. 2016;11:19.</Citation></Reference><Reference><Citation>Bakker IS, Snijders HS, Grossmann I, Karsten TM, Havenga K, Wiggers T. High mortality rates after nonelective colon cancer resection: results of a national audit. Colorectal Dis. 2016;18:612&#x2013;621.</Citation></Reference><Reference><Citation>Kwaan MR, Al-Refaie WB, Parsons HM, Chow CJ, Rothenberger DA, Habermann EB. Are right-sided colectomy outcomes different from left-sided colectomy outcomes?: study of patients with colon cancer in the ACS NSQIP database. JAMA Surg. 2013;148:504&#x2013;510.</Citation></Reference><Reference><Citation>Masoomi H, Buchberg B, Dang P, Carmichael JC, Mills S, Stamos MJ. Outcomes of right vs. left colectomy for colon cancer. J Gastrointest Surg. 2011;15:2023&#x2013;2028.</Citation></Reference><Reference><Citation>Smedh K, Birgisson H, Raab Y, Strand E, Karlsson C. Self-expanding stent in obstructing colorectal cancer. A new technique to avoid abdominal surgery. Lakartidningen. 2003;100:1982&#x2013;1986.</Citation></Reference><Reference><Citation>Amelung FJ, Ter Borg F, Consten EC, Siersema PD, Draaisma WA. Deviating colostomy construction versus stent placement as bridge to surgery for malignant left-sided colonic obstruction. Surg Endosc. 2016;30:5345&#x2013;5355.</Citation></Reference><Reference><Citation>Veld JV, Amelung FJ, Borstlap WAA, et al.; Dutch Snapshot Research Group. Changes in management of left-sided obstructive colon cancer: national practice and guideline implementation. J Natl Compr Canc Netw. 2019;17:1512&#x2013;1520.</Citation></Reference><Reference><Citation>Sartelli M, Weber DG, Kluger Y, et al. 2020 update of the WSES guidelines for the management of acute colonic diverticulitis in the emergency setting. World J Emerg Surg. 2020;15:32.</Citation></Reference><Reference><Citation>Kanaka S, Matsuda A, Yamada T, et al. Colonic stent as a bridge to surgery versus emergency resection for right-sided malignant large bowel obstruction: a meta-analysis. Surg Endosc. 2022;36:2760&#x2013;2770.</Citation></Reference><Reference><Citation>Amelung FJ, Consten ECJ, Siersema PD, Tanis PJ. A population-based analysis of three treatment modalities for malignant obstruction of the proximal colon: acute resection versus stent or stoma as a bridge to surgery. Ann Surg Oncol. 2016;23:3660&#x2013;3668.</Citation></Reference><Reference><Citation>Bokey EL, Chapuis PH, Fung C, et al. Postoperative morbidity and mortality following resection of the colon and rectum for cancer. Dis Colon Rectum. 1995;38:480&#x2013;486.</Citation></Reference><Reference><Citation>Lee MJ, Sayers AE, Drake TM, et al.; NASBO Steering Group and NASBO Collaborators. Malnutrition, nutritional interventions and clinical outcomes of patients with acute small bowel obstruction: results from a national, multicentre, prospective audit. BMJ Open. 2019;9:e029235.</Citation></Reference><Reference><Citation>Ceresoli M, Braga M, Zanini N, et al. Enhanced perioperative care in emergency general surgery: the WSES position paper. World J Emerg Surg. 2023;18:47.</Citation></Reference><Reference><Citation>Koterazawa Y, Oshikiri T, Takiguchi G, et al. Severe weight loss after minimally invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer at 5 years. BMC Gastroenterol. 2020;20:407.</Citation></Reference><Reference><Citation>Zhang Y, Tan S, Wu G. ESPEN practical guideline: clinical nutrition in surgery. Clin Nutr. 2021;40:5071.</Citation></Reference><Reference><Citation>Najafpour Z, Godarzi Z, Arab M, Yaseri M. Risk factors for falls in hospital in-patients: a prospective nested case control study. Int J Health Policy Manag. 2019;8:300&#x2013;306.</Citation></Reference><Reference><Citation>Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993;6:428&#x2013;442.</Citation></Reference><Reference><Citation>van Hooft JE, Veld JV, Arnold D, et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline&#x2014;update 2020. Endoscopy. 2020;52:389&#x2013;407.</Citation></Reference><Reference><Citation>Boeding JRE, Ramphal W, Rijken AM, et al. A systematic review comparing emergency resection and staged treatment for curable obstructing right-sided colon cancer. Ann Surg Oncol. 2021;28:3545&#x2013;3555.</Citation></Reference><Reference><Citation>Rodrigues-Pinto E, Morais R, Coelho C, Pereira P, Repici A, Macedo G. Bridge-to-surgery versus emergency surgery in the management of left-sided acute malignant colorectal obstruction&#x2014;efficacy, safety and long-term outcomes. Dig Liver Dis. 2019;51:364&#x2013;372.</Citation></Reference><Reference><Citation>Veld JV, Amelung FJ, Borstlap WAA, et al.; Dutch Snapshot Research Group. Comparison of decompressing stoma vs stent as a bridge to surgery for left-sided obstructive colon cancer. JAMA Surg. 2020;155:206&#x2013;215.</Citation></Reference><Reference><Citation>Veld JV, Amelung FJ, Borstlap WAA, et al.; Dutch Snapshot Research Group. Decompressing stoma as bridge to elective surgery is an effective strategy for left-sided obstructive colon cancer: a national, propensity-score matched study. Ann Surg. 2020;272:738&#x2013;743.</Citation></Reference><Reference><Citation>Amelung FJ, Mulder CL, Verheijen PM, Draaisma WA, Siersema PD, Consten EC. Acute resection versus bridge to surgery with diverting colostomy for patients with acute malignant left sided colonic obstruction: systematic review and meta-analysis. Surg Oncol. 2015;24:313&#x2013;321.</Citation></Reference><Reference><Citation>Boeding JRE, Cuperus IE, Rijken AM, et al. Postponing surgery to optimise patients with acute right-sided obstructing colon cancer&#x2014;a pilot study. Eur J Surg Oncol. 2023;49:106906.</Citation></Reference><Reference><Citation>Kane LT, Fang T, Galetta MS, et al. Propensity score matching: a statistical method. Clin Spine Surg. 2020;33:120&#x2013;122.</Citation></Reference><Reference><Citation>Lee KJ, Simpson JA. Introduction to multiple imputation for dealing with missing data. Respirology. 2014;19:162&#x2013;167.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40202196</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>The Impact of Follow-up Colonoscopy on Survival in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program: A Nationwide Study.</ArticleTitle><Pagination><StartPage>899</StartPage><EndPage>906</EndPage><MedlinePgn>899-906</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003771</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Various colorectal cancer screening programs are thought to be responsible for the decline in colorectal cancer incidence and mortality in developed countries. However, a few recently published studies indicate that many patients do not fully complete the preplanned colorectal cancer screening. Currently, there is a lack of high-volume data examining patient compliance and its impact on the screening program results.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the relationship between participation and compliance within the program and the mortality of patients who participate in the screening program.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Large database cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Nationwide colorectal cancer screening program of a European Union country (Lithuania).</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Data of patients aged 50 to 74 years who participated in the colorectal cancer screening program from January 2013 to December 2019 were extracted from a national database.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Mortality data were extracted on all persons who died from 2013 through December 2020. Patients were divided into 4 groups according to their adherence to the colonoscopy screening program.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,521,394 patients participated in the screening program. A positive fecal immunochemical test was detected for 127,503 patients (8.3%), of whom 55,202 (43.3%) proceeded with further colonoscopy. Patients who had a negative fecal immunochemical test result had the lowest mortality rates (4.9%), and patients who had a positive fecal immunochemical test result but did not undergo follow-up colonoscopy had the worst mortality rate (8.6%; p &lt; 0.001). The logistic regression model indicated that patients with a positive fecal immunochemical test and without a subsequent colonoscopy had a significantly increased mortality risk (OR 2.18; 95% CI, 2.12-2.24; p &lt; 0.001).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Lack of data on timing of colonoscopy, comorbidities, lifestyle factors, or previous medical history.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study indicates that noncompliers with colonoscopy, especially women, after a positive fecal immunochemical test are at a significantly increased all-cause mortality risk. See Video Abstract .</AbstractText><AbstractText Label="EL IMPACTO DE LA COLONOSCOPIA EN EL SEGUIMIENTO DE LA SUPERVIVENCIA EN UN PROGRAMA DE DETECCIN DEL CNCER COLORRECTAL, BASADO EN PRUEBAS INMUNOQUMICAS FECALES UN ESTUDIO A NIVEL NACIONAL" NlmCategory="UNASSIGNED">ANTECEDENTES:Se cree que varios programas de detecci&#xf3;n del c&#xe1;ncer colorrectal son responsables en la disminuci&#xf3;n de la incidencia y la mortalidad del c&#xe1;ncer colorrectal en los pa&#xed;ses desarrollados. Pocos estudios recientemente publicados, indican que muchos pacientes no completan el programa de detecci&#xf3;n planificado previamente del c&#xe1;ncer colorrectal. Actualmente, faltan datos de gran volumen que examinen el cumplimiento del paciente y su impacto en los resultados del programa de detecci&#xf3;n.OBJETIVO:Evaluar la relaci&#xf3;n entre participaci&#xf3;n y cumplimiento dentro del programa y la mortalidad de los pacientes que participaron en el programa de detecci&#xf3;n.DISE&#xd1;O:Estudio de cohorte de una gran base de datos.AJUSTE:Programa nacional de detecci&#xf3;n del c&#xe1;ncer colorrectal de un pa&#xed;s de la Uni&#xf3;n Europea (Lituania).PACIENTES:Datos de pacientes de entre 50 y 74 a&#xf1;os que participaron en el Programa de detecci&#xf3;n del c&#xe1;ncer colorrectal desde enero de 2013 hasta diciembre de 2019 de una base de datos nacional.PRINCIPALES MEDIDAS DE RESULTADO:Se extrajeron datos de mortalidad de todas las personas que fallecieron desde 2013 hasta diciembre de 2020. Los pacientes se dividieron en cuatro grupos seg&#xfa;n su adherencia al programa de detecci&#xf3;n mediante colonoscopia.RESULTADOS:Un total de 1,521,394 pacientes participaron en el programa de detecci&#xf3;n. Se detect&#xf3; una prueba inmunoqu&#xed;mica fecal positiva en 127,503 (8,3 %) pacientes, de los cuales 55,202 (43,3 %) procedieron a una colonoscopia adicional. Los pacientes con una prueba inmunoqu&#xed;mica fecal negativa tuvieron las tasas de mortalidad m&#xe1;s bajas y los que tuvieron una prueba inmunoqu&#xed;mica fecal positiva, pero no se sometieron a una colonoscopia de seguimiento, tuvieron las peores con un 4,9 % y un 8,6 % respectivamente, p &lt; 0,001. El modelo de regresi&#xf3;n log&#xed;stica indic&#xf3; que los pacientes con una prueba inmunoqu&#xed;mica fecal positiva y sin una colonoscopia posterior, ten&#xed;an un riesgo de mortalidad significativamente mayor (OR 2,18; IC del 95 %: 2,12-2,24; p &lt; 0,001).LIMITACIONES:Falta de datos sobre el momento de la colonoscopia, comorbilidades, factores de estilo de vida o el historial m&#xe9;dico previo.CONCLUSIONES:Nuestro estudio indica que los que no cumplieron con la colonoscopia, especialmente las mujeres, despu&#xe9;s de una prueba inmunoqu&#xed;mica fecal positiva, tienen un riesgo significativamente mayor de mortalidad por todas las causas. (Traducci&#xf3;n - Dr. Fidel Ruiz Healy).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jakubauskas</LastName><ForeName>Matas</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0789-2067</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Institute of Translational Health Research, Vilnius University, Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jasi&#x16b;nas</LastName><ForeName>Eugenijus</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Strupas</LastName><ForeName>Kestutis</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Poskus</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6931-6041</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003113" MajorTopicYN="Y">Colonoscopy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009780" MajorTopicYN="N">Occult Blood</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010349" MajorTopicYN="Y">Patient Compliance</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colonoscopy</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Fecal immunochemical test</Keyword><Keyword MajorTopicYN="N">Screening</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>9</Day><Hour>8</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40202196</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003771</ArticleId><ArticleId IdType="pii">00003453-202507000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209&#x2013;249.</Citation></Reference><Reference><Citation>Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60:681&#x2013;691.</Citation></Reference><Reference><Citation>Meester RGS, Doubeni CA, Lansdorp-Vogelaar I, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015;25:208&#x2013;213.e1.</Citation></Reference><Reference><Citation>Bretthauer M, L&#xf8;berg M, Wieszczy P, et al.; NordICC Study Group. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387:1547&#x2013;1556.</Citation></Reference><Reference><Citation>Dulskas A, Poskus T, Kildusiene I, et al. National colorectal cancer screening program in Lithuania: description of the 5-year performance on population level. Cancers (Basel). 2021;13:1129.</Citation></Reference><Reference><Citation>Poskus T, Strupas K, Mikalauskas S, et al. Initial results of the National Colorectal Cancer Screening Program in Lithuania. Eur J Cancer Prev. 2015;24:76&#x2013;80.</Citation></Reference><Reference><Citation>Mohl JT, Ciemins EL, Miller-Wilson LA, Gillen A, Luo R, Colangelo F. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020. JAMA Netw Open. 2023;6:e2251384.</Citation></Reference><Reference><Citation>Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152:1217&#x2013;1237.e3.</Citation></Reference><Reference><Citation>Zorzi M, Battagello J, Selby K, et al. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer. Gut. 2022;71:561&#x2013;567.</Citation></Reference><Reference><Citation>San Miguel Y, Demb J, Martinez ME, Gupta S, May FP. Time to colonoscopy after abnormal stool-based screening and risk for colorectal cancer incidence and mortality. Gastroenterology. 2021;160:1997&#x2013;2005.e3.</Citation></Reference><Reference><Citation>May FP, Yano EM, Provenzale D, et al. Barriers to follow-up colonoscopies for patients with positive results from fecal immunochemical tests during colorectal cancer screening. Clin Gastroenterol Hepatol. 2019;17:469&#x2013;476.</Citation></Reference><Reference><Citation>Partin MR, Gravely AA, Burgess JF Jr, et al. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results. Cancer. 2017;123:3502&#x2013;3512.</Citation></Reference><Reference><Citation>Jimbo M, Myers RE, Meyer B, et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann Fam Med. 2009;7:11&#x2013;16.</Citation></Reference><Reference><Citation>Rao SK, Schilling TF, Sequist TD. Challenges in the management of positive fecal occult blood tests. J Gen Intern Med. 2009;24:356&#x2013;360.</Citation></Reference><Reference><Citation>Issaka RB, Singh MH, Oshima SM, et al. Inadequate utilization of diagnostic colonoscopy following abnormal FIT results in an integrated safety-net system. Am J Gastroenterol. 2017;112:375&#x2013;382.</Citation></Reference><Reference><Citation>Inadomi JMMD, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575&#x2013;582.</Citation></Reference><Reference><Citation>Padula AM, Pressman AR, Vittinghoff E, et al. Placebo adherence and mortality in the heart and estrogen/progestin replacement study. Am J Med. 2012;125:804&#x2013;810.</Citation></Reference><Reference><Citation>Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303:1038&#x2013;1041.</Citation></Reference><Reference><Citation>Offiicial Statistic Portal. The population of Lithuania. Crude mortality rates. https://osp.stat.gov.lt/en/lietuvos-gyventojai-2022/mirtingumas/bendrieji-mirtingumo-rodikliai . Accessed December 31, 2024</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39508482</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Rectal Cancer Watch-and-Wait Management: Experience of 545 Patients From the US Rectal Cancer Research Group.</ArticleTitle><Pagination><StartPage>180</StartPage><EndPage>189</EndPage><MedlinePgn>180-189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003586</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The use of a watch-and-wait management strategy after a complete clinical response to neoadjuvant therapy for rectal cancer is increasing. However, insights into implementation, treatments, and outcomes on a national level in the United States are limited.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate and report on watch-and-wait management practices and outcomes in the United States.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Multicenter.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients with stage II or III rectal cancer who underwent intentional watch-and-wait management between January 2015 and August 2022.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Patient and tumor characteristics, neoadjuvant treatment and response, local cancer regrowth and metastasis, salvage surgery, overall survival, and disease-specific survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 545 patients from 33 centers, follow-up was 21 months (range, 9-37). Total neoadjuvant therapy or other types of neoadjuvant therapy were used in 395 (72%) and 150 (28%) patients, respectively. The estimated 3-year local regrowth rate was 23.8% (95% CI, 19.1%-29.4%). Patients with local regrowth had higher distant metastases incidence (14.2% vs 3.5%, p &lt; 0.001). Salvage surgery was performed in 74 of 84 patients (88%) with local regrowth and included rectal resection in 66 patients (89%) and local excision in 8 (11%). Of 64 salvage resections with known pathology results, 58 (91%) were margin-negative. Overall, 3-year overall survival was 94.8% (95% CI, 90.5%-97.2%) and 3-year disease-specific survival was 96.2% (95% CI, 91.8%-98.2%). Patients with and without local regrowth exhibited 3-year overall survival of 83.6% (95% CI, 68.4%-91.9%) and 97.7% (95% CI, 93.3%-99.2%), respectively.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This multicenter study indicates that the watch-and-wait approach for locally advanced rectal cancer is feasible with acceptable outcomes across a variety of geographical regions and practice settings in the United States. Local regrowth and distant metastasis rates were within published norms and salvage surgery proved effective. See Video Abstract .</AbstractText><AbstractText Label="MANEJO DE ESPERA Y OBSERVACIN DEL CNCER RECTAL EXPERIENCIA DE PACIENTES DEL GRUPO DE INVESTIGACIN DEL CNCER RECTAL DE EE UU" NlmCategory="UNASSIGNED">ANTECEDENTES:El uso de una estrategia de manejo de observaci&#xf3;n y espera despu&#xe9;s de una respuesta cl&#xed;nica completa a la terapia neoadyuvante para el c&#xe1;ncer de recto est&#xe1; aumentando. Sin embargo, los conocimientos sobre la implementaci&#xf3;n, los tratamientos y los resultados, a nivel nacional de los Estados Unidos, son limitados.OBJETIVO:Investigar e informar sobre las pr&#xe1;cticas y los resultados del manejo de observaci&#xf3;n y espera en los EE. UU.DISE&#xd1;O:Estudio retrospectivo.ESCENARIO:Multic&#xe9;ntrico.PACIENTES:Pacientes con c&#xe1;ncer de recto en estadio II o III que se sometieron a un manejo de observaci&#xf3;n y espera intencional entre enero de 2015 y agosto de 2022.PRINCIPALES MEDIDAS DE RESULTADOS:Caracter&#xed;sticas del paciente y del tumor, tratamiento neoadyuvante y respuesta, recrecimiento local del c&#xe1;ncer y met&#xe1;stasis, cirug&#xed;a de rescate, supervivencia general y espec&#xed;fica de la enfermedad.RESULTADOS:Entre 545 pacientes de 33 centros, el seguimiento fue de 21 meses (rango, 9-37). Se utiliz&#xf3; terapia neoadyuvante total u otros tipos de neoadyuvancia en 395 (72%) y 150 (28%) de los pacientes, respectivamente. La tasa estimada de recrecimiento local a 3 a&#xf1;os fue del 23,8% (IC del 95%: 19,1-29,4%). Los pacientes con recrecimiento local tuvieron una mayor incidencia de met&#xe1;stasis a distancia (14,2% frente a 3,5%, p &lt; 0,001). Se realiz&#xf3; cirug&#xed;a de rescate en 74/84 (88%) pacientes con recrecimiento local e incluy&#xf3; resecci&#xf3;n rectal en 66 (89%) y escisi&#xf3;n local en 8 (11%). De 64 resecciones de rescate con resultados patol&#xf3;gicos conocidos, 58 (91%) fueron m&#xe1;rgenes negativos. En general, la supervivencia global a los 3 a&#xf1;os fue del 94,8 % (IC del 95 %: 90,5-97,2 %) y la supervivencia espec&#xed;fica de la enfermedad a los 3 a&#xf1;os del 96,2 % (IC del 95 %: 91,8-98,2 %). Los pacientes con y sin recrecimiento local mostraron una supervivencia global a los 3 a&#xf1;os del 83,6 % (IC del 95 %: 68,4-91,9 %) y del 97,7 % (IC del 95 %: 93,3-99,2 %), respectivamente.LIMITACIONES:Estudio retrospectivo.CONCLUSI&#xd3;N:Este estudio multic&#xe9;ntrico indica que el enfoque de observaci&#xf3;n y espera para el c&#xe1;ncer rectal localmente avanzado es factible con resultados aceptables en una variedad de regiones geogr&#xe1;ficas y entornos de pr&#xe1;ctica en los EE. UU. Las tasas de recrecimiento local y met&#xe1;stasis a distancia estuvieron dentro de las normas publicadas y la cirug&#xed;a de rescate result&#xf3; eficaz. (Traducci&#xf3;n-Dr Yolanda Colorado ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-0187-4255</Identifier><AffiliationInfo><Affiliation>Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widmar</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monson</LastName><ForeName>John R T</ForeName><Initials>JRT</Initials><AffiliationInfo><Affiliation>Northwell Health, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleming</LastName><ForeName>Fergal J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Rochester Medical Center, Rochester, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Arden M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Stanford University, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogel</LastName><ForeName>Jon D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>US Rectal Cancer Research Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057832" MajorTopicYN="Y">Watchful Waiting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES:">El uso de una estrategia de manejo de observaci&#xf3;n y espera despu&#xe9;s de una respuesta cl&#xed;nica completa a la terapia neoadyuvante para el c&#xe1;ncer de recto est&#xe1; aumentando. Sin embargo, los conocimientos sobre la implementaci&#xf3;n, los tratamientos y los resultados, a nivel nacional de los Estados Unidos, son limitados.</AbstractText><AbstractText Label="OBJETIVO:">Investigar e informar sobre las pr&#xe1;cticas y los resultados del manejo de observaci&#xf3;n y espera en los EE. UU.</AbstractText><AbstractText Label="DISE&#xd1;O:">Estudio retrospectivo.</AbstractText><AbstractText Label="ESCENARIO:">Multic&#xe9;ntrico.</AbstractText><AbstractText Label="PACIENTES:">Pacientes con c&#xe1;ncer de recto en estadio II o III que se sometieron a un manejo de observaci&#xf3;n y espera intencional entre enero de 2015 y agosto de 2022.</AbstractText><AbstractText Label="PRINCIPALES MEDIDAS DE RESULTADOS:">Caracter&#xed;sticas del paciente y del tumor, tratamiento neoadyuvante y respuesta, recrecimiento local del c&#xe1;ncer y met&#xe1;stasis, cirug&#xed;a de rescate, supervivencia general y espec&#xed;fica de la enfermedad.</AbstractText><AbstractText Label="RESULTADOS:">Entre 545 pacientes de 33 centros, el seguimiento fue de 21 meses (rango, 9&#x2013;37). Se utiliz&#xf3; terapia neoadyuvante total u otros tipos de neoadyuvancia en 395 (72%) y 150 (28%) de los pacientes, respectivamente. La tasa estimada de recrecimiento local a 3 a&#xf1;os fue del 23,8% (IC del 95%: 19,1&#x2013;29,4%). Los pacientes con recrecimiento local tuvieron una mayor incidencia de met&#xe1;stasis a distancia (14,2% frente a 3,5%, p &lt; 0,001). Se realiz&#xf3; cirug&#xed;a de rescate en 74/84 (88%) pacientes con recrecimiento local e incluy&#xf3; resecci&#xf3;n rectal en 66 (89%) y escisi&#xf3;n local en 8 (11%). De 64 resecciones de rescate con resultados patol&#xf3;gicos conocidos, 58 (91%) fueron m&#xe1;rgenes negativos. En general, la supervivencia global a los 3 a&#xf1;os fue del 94,8 % (IC del 95 %: 90,5&#x2013;97,2 %) y la supervivencia espec&#xed;fica de la enfermedad a los 3 a&#xf1;os del 96,2 % (IC del 95 %: 91,8&#x2013;98,2 %). Los pacientes con y sin recrecimiento local mostraron una supervivencia global a los 3 a&#xf1;os del 83,6 % (IC del 95 %: 68,4&#x2013;91,9 %) y del 97,7 % (IC del 95 %: 93,3&#x2013;99,2 %), respectivamente.</AbstractText><AbstractText Label="LIMITACIONES:">Estudio retrospectivo.</AbstractText><AbstractText Label="CONCLUSI&#xd3;N:">Este estudio multic&#xe9;ntrico indica que el enfoque de observaci&#xf3;n y espera para el c&#xe1;ncer rectal localmente avanzado es factible con resultados aceptables en una variedad de regiones geogr&#xe1;ficas y entornos de pr&#xe1;ctica en los EE. UU. Las tasas de recrecimiento local y met&#xe1;stasis a distancia estuvieron dentro de las normas publicadas y la cirug&#xed;a de rescate result&#xf3; eficaz. <i>(Pre-proofed version)</i></AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></OtherAbstract><InvestigatorList><Investigator ValidYN="Y"><LastName>Gupta</LastName><ForeName>Abhinav</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Price</LastName><ForeName>Adam D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Booth</LastName><ForeName>Adam L</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores</LastName><ForeName>Aileen De Mucha</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Aimal</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fichera</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Alexander T</ForeName><Initials>AT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayman</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fa</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuhnen</LastName><ForeName>Angela H</ForeName><Initials>AH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Melio</LastName><ForeName>Anna A</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fabrizio</LastName><ForeName>Anne C</ForeName><Initials>AC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Loria</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villano</LastName><ForeName>Anthony M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caycedo-Marulanda</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>Arden</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amir</LastName><ForeName>Arslan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duby</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shogan</LastName><ForeName>Benjamin D</ForeName><Initials>BD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosamond</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Brian N</ForeName><Initials>BN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monahan</LastName><ForeName>Brian V</ForeName><Initials>BV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newton</LastName><ForeName>Carla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hong</LastName><ForeName>Christine L</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aquina</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Munroe</LastName><ForeName>Cody</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donahue</LastName><ForeName>Colleen A</ForeName><Initials>CA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hayden</LastName><ForeName>Dana M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kleiman</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>David D Q</ForeName><Initials>DDQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dietz</LastName><ForeName>David W</ForeName><Initials>DW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keller</LastName><ForeName>Deborah S</ForeName><Initials>DS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strungs</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flemming</LastName><ForeName>Fergal</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romero-Hernandez</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saidi</LastName><ForeName>Hela</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Govekar</LastName><ForeName>Henry R</ForeName><Initials>HR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paquette</LastName><ForeName>Ian M</ForeName><Initials>IM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klausner</LastName><ForeName>Jake</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Jeanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farma</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller-Ocuin</LastName><ForeName>Jennifer L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rytych</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knight</LastName><ForeName>Jimmie</ForeName><Initials>J</Initials><Suffix>3rd</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Marks M D</LastName><ForeName>John H</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monson</LastName><ForeName>John R T</ForeName><Initials>JRT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vogel</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Abelson</LastName><ForeName>Jonathan S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kohn</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saraidaridis</LastName><ForeName>Julia T</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wells</LastName><ForeName>Katerina K O</ForeName><Initials>KKO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Akemi Tavares</LastName><ForeName>Kelli Beth</ForeName><Initials>KB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cologne</LastName><ForeName>Kyle G</ForeName><Initials>KG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Temple</LastName><ForeName>Larissa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bustamente-Lopez</LastName><ForeName>Leo</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Force</LastName><ForeName>Luanne</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Varma</LastName><ForeName>Madhulika G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferrara</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Widmar</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whiteford</LastName><ForeName>Mark H</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalady</LastName><ForeName>Matthew F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hill</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chang</LastName><ForeName>Melissa I</ForeName><Initials>MI</Initials></Investigator><Investigator ValidYN="Y"><LastName>McGee</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matos</LastName><ForeName>Monique C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Piyush</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aoun</LastName><ForeName>Rami James N</ForeName><Initials>RJN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daugherty</LastName><ForeName>Ray S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cleary</LastName><ForeName>Robert K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guevara</LastName><ForeName>Salvador G</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Younan</LastName><ForeName>Samuel A</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Samuel H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boatman</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greco</LastName><ForeName>Stephanie H</ForeName><Initials>SH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russell</LastName><ForeName>Tara A</ForeName><Initials>TA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prasad Poola</LastName><ForeName>Taylor Penn V</ForeName><Initials>TPV</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Virgilio V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poylin</LastName><ForeName>Vitaliy Y</ForeName><Initials>VY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simianu</LastName><ForeName>Vlad V</ForeName><Initials>VV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gaertner</LastName><ForeName>Wolfgang B</ForeName><Initials>WB</Initials></Investigator><Investigator ValidYN="Y"><LastName>To</LastName><ForeName>Yue-Yun</ForeName><Initials>YY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sun</LastName><ForeName>Zhifei</ForeName><Initials>Z</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>24</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>7</Day><Hour>8</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39508482</ArticleId><ArticleId IdType="mid">NIHMS2083505</ArticleId><ArticleId IdType="pmc">PMC12232607</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003586</ArticleId><ArticleId IdType="pii">00003453-990000000-00789</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:1139&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">36240850</ArticleId></ArticleIdList></Reference><Reference><Citation>Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum. 1998;41:1087&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">9749491</ArticleId></ArticleIdList></Reference><Reference><Citation>Habr-Gama A, Oliva Perez R, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1356472</ArticleId><ArticleId IdType="pubmed">15383798</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenfeld SJ, Davis BR, Vogel JD, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer 2023 supplement. Dis Colon Rectum. 2024;67:18&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">37647138</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Valk MJM, Hilling DE, Bastiaannet E, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch &amp; Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537&#x2013;2545.</Citation><ArticleIdList><ArticleId IdType="pubmed">29976470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadi SA, Malcomson L, Ensor J, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018;3:825&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pubmed">30318451</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin RI, Schiff JP, Shetty AS, et al. Circumferential resection margin as predictor of nonclinical complete response in nonoperative management of rectal cancer. Dis Colon Rectum. 2023;66:973&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">36876988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dattani M, Heald RJ, Goussous G, et al. Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018;268:955&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">29746338</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Aguilar J, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;40:2546&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362876</ArticleId><ArticleId IdType="pubmed">35483010</ArticleId></ArticleIdList></Reference><Reference><Citation>Habr-Gama A, S&#xe3;o Juli&#xe3;o GP, Fernandez LM, et al. Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: it may take longer than you think! Dis Colon Rectum. 2019;62:802&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">31188180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Rodriguez RM, Patil S, Gollub MJ, et al. Organ preservation in patients with rectal cancer treated with total neoadjuvant therapy. Dis Colon Rectum. 2021;64:1463&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820240</ArticleId><ArticleId IdType="pubmed">34508014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rettig RL, Beard BW, Ryoo JJ, et al. Total neoadjuvant therapy significantly increases complete clinical response. Dis Colon Rectum. 2023;66:374&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">35239525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez LM, S&#xe3;o Juli&#xe3;o GP, Figueiredo NL, et al. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch &amp; Wait Database: a retrospective, international, multicentre registry study. Lancet Oncol. 2021;22:43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">33316218</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JJ, Strombom P, Chow OS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol. 2019;5:e185896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459120</ArticleId><ArticleId IdType="pubmed">30629084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez LM, S&#xe3;o Juli&#xe3;o GP, Renehan AG, et al. The risk of distant metastases in patients with clinical complete response managed by watch and wait after neoadjuvant therapy for rectal cancer: the influence of local regrowth in the International Watch and Wait Database. Dis Colon Rectum. 2023;66:41&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">36515514</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman BC, Lai SH, Friedrich T, et al. Rectal cancer: clinical and molecular predictors of a complete response to total neoadjuvant therapy. Dis Colon Rectum. 2023;66:521&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">34984995</ArticleId></ArticleIdList></Reference><Reference><Citation>Loria A, Tejani MA, Temple LK, et al. Practice patterns for organ preservation in US patients with rectal cancer, 2006&#x2013;2020. JAMA Oncol. 2024;10:79&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10636650</ArticleId><ArticleId IdType="pubmed">37943566</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammour T, Price BA, Krause KJ, Chang GJ. Nonoperative management or &#x2018;watch and wait&#x2019; for rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy: a critical appraisal. Ann Surg Oncol. 2017;24:1904&#x2013;1915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6106774</ArticleId><ArticleId IdType="pubmed">28324284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:501&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">28479372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai S, Widmar M, Monson J, Morris A, Fleming F, Vogel J. Rectal cancer watch &amp; wait strategy: the U.S. Rectal Cancer Research Group experience with 545 patients [ASCRS abstract T103]. Dis Colon Rectum. 2024;67:e504&#x2013;e505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12232607</ArticleId><ArticleId IdType="pubmed">39508482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38902840</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Bowel Dysfunction After Colon Cancer Surgery: A Prospective, Longitudinal, Multicenter Study.</ArticleTitle><Pagination><StartPage>1322</StartPage><EndPage>1331</EndPage><MedlinePgn>1322-1331</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003358</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Longitudinal studies on functional outcomes after colon resection are limited.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate bowel dysfunction and related distress 1 and 3 years after colon resection using the low anterior resection syndrome score as well as specific validated items.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This study presents the long-term results of bowel dysfunction and related distress based on the Quality of Life in Colon Cancer study, an observational, prospective multicenter study of patients with newly diagnosed colon cancer.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">The study was conducted at 21 Swedish and Danish surgical centers between 2015 and 2019.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All patients who underwent right-sided or left-sided colon resection were considered eligible. Exclusion criteria were age younger than 18 years, cognitive impairment, or inability to understand Swedish/Danish. Patients completed extensive questionnaires at diagnosis and after 1 and 3 years. Clinical data were supplemented by national quality registries.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The low anterior resection syndrome score, specific bowel symptoms, and patient-reported distress were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1221 patients (83% response rate), 17% reported major low anterior resection syndrome 1 year after either type of resection; this finding was consistent at 3 years (17% right, 16% left). In the long-term, the only significant difference between types of resections was a high occurrence of loose stools after right-sided resections. Overall, less than one-fifth of patients experienced distress, with women reporting more frequent symptoms and greater distress. In particular, incontinence and loose stools correlated strongly with distress.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Absence of prediagnosis bowel function data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study indicates that bowel function remains largely intact after colon resection, with only a minority reporting significant distress. Adverse outcomes were more common among women. The occurrence of loose stools after right-sided resection and the association between incontinence, loose stools, and distress highlights a need for postoperative evaluations and more thorough assessments beyond the low anterior resection syndrome score when evaluating patients with colon cancer. See the Video Abstract .</AbstractText><AbstractText Label="DISFUNCIONAMIENTO INTESTINAL DESPUS DE LA CIRUGA POR CNCER DE COLON ESTUDIO PROSPECTIVO, LONGITUDINAL Y MULTICNTRICO" NlmCategory="UNASSIGNED">ANTECEDENTES:Los estudios longitudinales sobre el resultado funcional despu&#xe9;s de una resecci&#xf3;n c&#xf3;lica son limitados.OBJETIVO:Examinar la disfunci&#xf3;n intestinal y el malestar relacionado uno y tres a&#xf1;os despu&#xe9;s de la resecci&#xf3;n del colon utilizando la puntuaci&#xf3;n de referencia en el s&#xed;ndrome de resecci&#xf3;n anterior baja (LARS), as&#xed; como otros &#xed;tems de validez espec&#xed;fica.DISE&#xd1;O:Este estudio presenta los resultados a largo plazo de la disfunci&#xf3;n intestinal y la angustia relacionada seg&#xfa;n el estudio QoLiCOL (Quality of Life in COLon cancer), un analisis observacional, prospectivo y multic&#xe9;ntrico de pacientes con c&#xe1;ncer de colon reci&#xe9;n diagnosticado.AJUSTES:El presente estudio fu&#xe9; realizado en 21 centros quir&#xfa;rgicos suecos y daneses entre 2015 y 2019.PACIENTES:Todos los pacientes sometidos a resecci&#xf3;n de colon, tanto del lado derecho como el izquierdo se consideraron elegibles. Los criterios de exclusi&#xf3;n fueron tener menos de 18 a&#xf1;os, deterioro cognitivo o incapacidad para entender sueco/dan&#xe9;s. Los pacientes completaron extensos cuestionarios en el momento del diagn&#xf3;stico y despu&#xe9;s de uno y tres a&#xf1;os. Los datos cl&#xed;nicos se complementaron con los registros de calidad binacionales.PRINCIPALES MEDIDAS DE RESULTADO:Se evaluaron los s&#xed;ntomas intestinales espec&#xed;ficos, la puntuaci&#xf3;n LARS y la angustia manifestada por cada paciente.RESULTADOS:De 1221 pacientes (tasa de respuesta del 83%), el 17% inform&#xf3; LARS mayor un a&#xf1;o despu&#xe9;s de cualquier tipo de resecci&#xf3;n, consistente a los tres a&#xf1;os (17% derecha, 16% izquierda). A largo plazo, la &#xfa;nica diferencia significativa entre los tipos de resecci&#xf3;n fue una alta incidencia de heces liquidas despu&#xe9;s de las resecciones del lado derecho. En general, menos de una quinta parte de los pacientes experimentaron angustia, y fu&#xe9; la poblacion femenina qui&#xe9;n inform&#xf3; de s&#xed;ntomas m&#xe1;s frecuentes y de mayor angustia. En particular, la incontinencia y las heces liquidas se correlacionaron fuertemente con la angustia.LIMITACIONES:Ausencia de datos de funci&#xf3;n intestinal previos al diagn&#xf3;stico.CONCLUSIONES:Nuestro estudio indica que la funci&#xf3;n intestinal permanece en gran medida intacta despu&#xe9;s de la resecci&#xf3;n del colon, y s&#xf3;lo una minor&#xed;a reporta malestar significativo. Los resultados adversos fueron m&#xe1;s comunes en la poblaci&#xf3;n femenina. La aparici&#xf3;n de heces liquidas despu&#xe9;s de la resecci&#xf3;n del lado derecho y la asociaci&#xf3;n entre incontinencia, heces liquidas y malestar resalta la necesidad de evaluaciones postoperatorias y valoraciones m&#xe1;s exhaustivas m&#xe1;s all&#xe1; de la puntuaci&#xf3;n LARS al evaluar a los pacientes con c&#xe1;ncer de colon. (Traducci&#xf3;n-Dr. Xavier Delgadillo ).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sandberg</LastName><ForeName>Sofia J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-5900-4717</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasselius</LastName><ForeName>Viktor A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angenete</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Region V&#xe4;stra G&#xf6;taland, Sahlgrenska University Hospital/&#xd6;stra, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02530593</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>VGFOUREG-557431, VGFOUREG-644441, VGFOUREG-733172</GrantID><Agency>The Healthcare sub-committee, Region V&#xc3;&#xa4;stra G&#xc3;&#xb6;taland</Agency><Country/></Grant><Grant><GrantID>VR2021-01025, VR2017-01103</GrantID><Agency>the Swedish Research Council</Agency><Country/></Grant><Grant><GrantID>22 2265 Pj, 19 0333 Pj</GrantID><Agency>the Swedish Cancer Society</Agency><Country/></Grant><Grant><GrantID>FB22-64</GrantID><Agency>Assar Gabrielsson foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="Y">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005242" MajorTopicYN="N">Fecal Incontinence</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="N">Constipation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>9</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>20</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38902840</ArticleId><ArticleId IdType="pmc">PMC11373893</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003358</ArticleId><ArticleId IdType="pii">00003453-202410000-00017</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Keane C, Fearnhead NS, Bordeianou LG, et al. ; LARS International Collaborative Group. International consensus definition of low anterior resection syndrome. Dis Colon Rectum. 2020;63:274&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034376</ArticleId><ArticleId IdType="pubmed">32032141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol. 2012;13:e403&#x2013;e408.</Citation><ArticleIdList><ArticleId IdType="pubmed">22935240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandberg S, Asplund D, Bisgaard T, et al. . Low anterior resection syndrome in a Scandinavian population of patients with rectal cancer: a longitudinal follow-up within the QoLiRECT study. Colorectal Dis. 2020;22:1367&#x2013;1378.</Citation><ArticleIdList><ArticleId IdType="pubmed">32346917</ArticleId></ArticleIdList></Reference><Reference><Citation>Keane C, Wells C, O&#x2019;Grady G, Bissett IP. Defining low anterior resection syndrome: a systematic review of the literature. Colorectal Dis. 2017;19:713&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pubmed">28612460</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkuijl SJ, Jonker JE, Trzpis M, Burgerhof JGM, Broens PMA, Furn&#xe9;e EJB. Functional outcomes of surgery for colon cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2021;47:960&#x2013;969.</Citation><ArticleIdList><ArticleId IdType="pubmed">33277056</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchli C, Martling A, Sj&#xf6;vall A. Low anterior resection syndrome after right- and left-sided resections for colonic cancer. BJS Open. 2019;3:387&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551391</ArticleId><ArticleId IdType="pubmed">31183455</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen HM, Elfeki H, Emmertsen KJ, Laurberg S. Long-term bowel dysfunction after right-sided hemicolectomy for cancer. Acta Oncol. 2020;59:1240&#x2013;1245.</Citation><ArticleIdList><ArticleId IdType="pubmed">32501750</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen HM, Krogh K, Borre M, et al. . Chronic loose stools following right-sided hemicolectomy for colon cancer and the association with bile acid malabsorption and small intestinal bacterial overgrowth. Colorectal Dis. 2023;25:600&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">36347822</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfeki H, Larsen HM, Emmertsen KJ, et al. . Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life. Br J Surg. 2019;106:142&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">30211443</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkuijl SJ, Furn&#xe9;e EJB, Kelder W, et al. . Long-term bowel dysfunction and decline in quality of life following surgery for colon cancer: call for personalized screening and treatment. Dis Colon Rectum. 2022;65:1531&#x2013;1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645552</ArticleId><ArticleId IdType="pubmed">35982522</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdeburg J, Glatz N, Post S, Kienle P, Rickert A. Long-term functional outcome of colonic resections: how much does faecal impairment influence quality of life? Colorectal Dis. 2016;18:O405&#x2013;O413.</Citation><ArticleIdList><ArticleId IdType="pubmed">27647736</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012;255:922&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">22504191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakash RA, Hutton JL, J&#xf8;rstad-Stein EC, Gates S, Lamb SE. Maximising response to postal questionnaires&#x2014;a systematic review of randomised trials in health research. BMC Med Res Methodol. 2006;6:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421421</ArticleId><ArticleId IdType="pubmed">16504090</ArticleId></ArticleIdList></Reference><Reference><Citation>Moberger P, Sk&#xf6;ldberg F, Birgisson H. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity. Acta Oncol. 2018;57:1611&#x2013;1621.</Citation><ArticleIdList><ArticleId IdType="pubmed">30477372</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein MF, G&#xf6;genur I, Ingeholm P, Njor SH, Iversen LH, Emmertsen KJ; DCCG Validation Group. Validation of the Danish Colorectal Cancer Group (DCCG.dk) database&#x2014;on behalf of the Danish Colorectal Cancer Group. Colorectal Dis. 2020;22:2057&#x2013;2067.</Citation><ArticleIdList><ArticleId IdType="pubmed">32894818</ArticleId></ArticleIdList></Reference><Reference><Citation>Steineck G, Helgesen F, Adolfsson J, et al. ; Scandinavian Prostatic Cancer Group Study Number 4. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">12226149</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul T, Ahlberg M, Biondo S, et al. . International validation of the low anterior resection syndrome score. Ann Surg. 2014;259:728&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pubmed">23598379</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing.
Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/. Accessed September 1, 2023.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>van Heinsbergen M, Van der Heijden JAG, Stassen LP, et al. . The low anterior resection syndrome in a reference population: prevalence and predictive factors in the Netherlands. Colorectal Dis. 2020;22:46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">31344293</ArticleId></ArticleIdList></Reference><Reference><Citation>Juul T, Elfeki H, Christensen P, Laurberg S, Emmertsen KJ, Bager P. Normative data for the low anterior resection syndrome score (LARS Score). Ann Surg. 2019;269:1124&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulskas A, Kavaliauskas P, Kulikauskas E, et al. . Low anterior resection syndrome: what have we learned assessing a large population? J Clin Med. 2022;11:4752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9410299</ArticleId><ArticleId IdType="pubmed">36012991</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon J, Ehlebracht A, Cwintal M, et al. . Low anterior resection syndrome in a reference North American sample: prevalence and associated factors. J Am Coll Surg. 2023;237:679&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">37466264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock D, Angenete E, Gonzales E, Heath J, Haglind E. Assessing health, quality of life and urogenital function in a sample of the Swedish general population: a cross-sectional study. BMJ Open. 2018;8:e021974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5942440</ArticleId><ArticleId IdType="pubmed">29730632</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FE, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33:818&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1379343</ArticleId><ArticleId IdType="pubmed">1624166</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter SA, Kjellstr&#xf6;m L, Nyhlin H, Talley NJ, Agr&#xe9;us L. Assessment of normal bowel habits in the general adult population: the Popcol study. Scand J Gastroenterol. 2010;45:556&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">20205503</ArticleId></ArticleIdList></Reference><Reference><Citation>Yde J, Larsen HM, Laurberg S, Krogh K, Moeller HB. Chronic diarrhoea following surgery for colon cancer-frequency, causes and treatment options. Int J Colorectal Dis. 2018;33:683&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">29589108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope C, Reilly J, Lund J, Andreyev H. Systematic review: the effect of right hemicolectomy for cancer on postoperative bowel function. Support Care Cancer. 2020;28:4549&#x2013;4559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7447648</ArticleId><ArticleId IdType="pubmed">32430603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohigashi S, Hoshino Y, Ohde S, Onodera H. Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg Today. 2011;41:1200&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">21874415</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38582749</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-3095</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of nursing knowledge</Title><ISOAbbreviation>Int J Nurs Knowl</ISOAbbreviation></Journal><ArticleTitle>Prevalence of NANDA-I Nursing Diagnoses in patients with heart failure: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>106</StartPage><EndPage>119</EndPage><MedlinePgn>106-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/2047-3095.12467</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This research quantitatively explored the prevalence of NANDA-I nursing diagnoses related to the care of patients experiencing heart failure.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A systematic review and meta-analysis were conducted with the systematic review protocol registered in PROSPERO (registration number: CRD42022382565).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Systematic searches were performed between March and April 2022, including peer review for selection, quality assessment, data extraction, and analysis of all included studies. A subsequent meta-analysis was performed, focusing on the proportion of nursing diagnoses in patients with heart failure. The logistic random effects model with maximum likelihood estimation assessed the combined proportion, and heterogeneity between studies was evaluated using the I<sup>2</sup> statistic. The goodness-of-fit of the meta-analysis results was assessed using the leave-one-out method and by evaluating publication bias through contour-enhanced funnel plots.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">PubMed, SCOPUS, CINAHL, WOS, and Embase were used.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 11 studies that met the eligibility criteria, 44 nursing diagnoses were identified as most frequently occurring in patients experiencing heart failure, and only 16 diagnoses appeared in more than one publication. The combined mean proportion was 35.73% (95% CI&#xa0;=&#xa0;[26.67%; 48.56%]), indicating the presence of heterogeneity based on the I<sup>2</sup> value. However, no publication bias was observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of the meta-analysis suggest priority diagnoses in individuals with heart failure, such as deficient knowledge (00126). Additionally, secondary diagnoses, such as activity intolerance (00092), excess fluid volume (00026), and ineffective breathing pattern (00032), were identified as responses to decreased cardiac output (00029). Less prevalent nursing diagnoses were associated with deterioration of health status and the need for hospitalization.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Investigar cuantitativamente la prevalencia de diagn&#xf3;sticos de enfermer&#xed;a NANDA-I asociados con la atenci&#xf3;n de pacientes con insuficiencia card&#xed;aca. DISE&#xd1;O: Revisi&#xf3;n sistem&#xe1;tica y metan&#xe1;lisis. El protocolo de revisi&#xf3;n sistem&#xe1;tica qued&#xf3; registrado en PROSPERO) n&#xfa;mero de registro: CRD42022382565). M&#xc9;TODOS: Se realizaron b&#xfa;squedas sistem&#xe1;ticas entre marzo y abril de 2022, llev&#xe1;ndose a cabo una revisi&#xf3;n por pares sobre la selecci&#xf3;n, evaluaci&#xf3;n de calidad, extracci&#xf3;n de datos y an&#xe1;lisis de todos los estudios incluidos. Se realiz&#xf3; un metan&#xe1;lisis posterior centrado en la proporci&#xf3;n de diagn&#xf3;sticos de enfermer&#xed;a en pacientes con insuficiencia card&#xed;aca. El modelo log&#xed;stico de efectos aleatorios con estimaci&#xf3;n de m&#xe1;xima verosimilitud evalu&#xf3; la proporci&#xf3;n combinada y la heterogeneidad entre los estudios se evalu&#xf3; mediante el estad&#xed;stico I<sup>2</sup>. La bondad de ajuste de los resultados del metan&#xe1;lisis se evalu&#xf3; mediante el m&#xe9;todo Leave-one-out y la evaluaci&#xf3;n del sesgo de publicaci&#xf3;n mediante gr&#xe1;ficos de embudo (funnel plot), denominado Contour-Enhanced Funnel Plot.</AbstractText><AbstractText Label="FUENTES DE DATOS" NlmCategory="UNASSIGNED">PubMed, SCOPUS, CINAHL, WOS, Embase.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">En los 11 estudios que cumplieron con los criterios de elegibilidad, se identificaron 44 diagn&#xf3;sticos de enfermer&#xed;a aunque s&#xf3;lo 16 diagn&#xf3;sticos aparecieron en m&#xe1;s de una publicaci&#xf3;n. La proporci&#xf3;n media combinada fue del 35,73% (IC del 95%)&#xa0;=&#xa0;[26,67%; 48,56%]), y el valor de I<sup>2</sup> indica la presencia de heterogeneidad, aunque no hay sesgo de publicaci&#xf3;n. CONCLUSI&#xd3;N: Los resultados de este metaan&#xe1;lisis indican que habr&#xed;a diagn&#xf3;sticos prioritarios en personas con insuficiencia card&#xed;aca, como Conocimientos deficientes (00126). Adem&#xe1;s, se han identificado otros diagn&#xf3;sticos de enfermer&#xed;a como diagn&#xf3;sticos secundarios: Intolerancia a la actividad (00092), Exceso de volumen de l&#xed;quidos (00026) y Patr&#xf3;n respiratorio ineficaz (00032), que ser&#xed;a la respuesta a Disminuci&#xf3;n del gasto card&#xed;aco (00029). Adem&#xe1;s de diagn&#xf3;sticos de enfermer&#xed;aa menos prevalentes relacionados con el deterioro del estado de salud y la necesidad de hospitalizaci&#xf3;n.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. International Journal of Nursing Knowledge published by Wiley Periodicals LLC on behalf of NANDA International.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paneque-S&#xe1;nchez-Toscano</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8527-4913</Identifier><AffiliationInfo><Affiliation>Research Group CTS 1050 Complex Care, Chronicity and Health Outcomes, Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porcel-G&#xe1;lvez</LastName><ForeName>Ana-Mar&#xed;a</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-8461-6379</Identifier><AffiliationInfo><Affiliation>Leadership Research Group CTS 1050 Complex Care, Chronicity and Health Outcomes, Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allande-Cuss&#xf3;</LastName><ForeName>Regina</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8325-0838</Identifier><AffiliationInfo><Affiliation>Research Group CTS 1050 Complex Care, Chronicity and Health Outcomes, Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carri&#xf3;n-Camacho</LastName><ForeName>Mar&#xed;a-Reyes</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Sevilla, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Nurs Knowl</MedlineTA><NlmUniqueID>101582422</NlmUniqueID><ISSNLinking>2047-3087</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009733" MajorTopicYN="Y">Nursing Diagnosis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072917" MajorTopicYN="N">Standardized Nursing Terminology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">evidence&#x2010;based nursing</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">nursing diagnosis</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>9</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>7</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>6</Day><Hour>22</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38582749</ArticleId><ArticleId IdType="pmc">PMC11707979</ArticleId><ArticleId IdType="doi">10.1111/2047-3095.12467</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Azzolin, K. , Souza, E. N. D. , Ruschel, K. B. , Mussi, C. M. , Lucena, A. D. F. , &amp; Rabelo, E. R. (2012). Consenso de diagn&#xf3;sticos, resultados e interven&#xe7;&#xf5;es de enfermagem para pacientes com insufici&#xea;ncia cardiaca em domic&#xed;lio. Revista Ga&#xfa;cha de Enfermagem, 33, 56&#x2013;63. 10.1590/S1983-14472012000400007</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1983-14472012000400007</ArticleId><ArticleId IdType="pubmed">23596917</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi, S. , R&#xfc;cker, G. , &amp; Schwarzer, G. (2019). How to perform a meta&#x2010;analysis with R: A practical tutorial. Evidence&#x2010;based Mental Health, 22(4), 153&#x2013;160. 10.1136/ebmental-2019-300117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro, C. S. , Oliveira, A. P. , Lopes, J. L. , Bachion, M. M. , Herdman, T. H. , Moorhead, S. A. , &amp; Barros, A. L. (2016). Outpatient clinic for health education: Contribution to self&#x2010;management and self&#x2010;care for people with heart failure. International Journal of Nursing Knowledge, 27(1), 49&#x2013;55. 10.1111/2047-3095.12071</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12071</ArticleId><ArticleId IdType="pubmed">25612229</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro, C. S. , Lopes, C. T. , Lopes, J. L. , Santos, V. B. , Bachion, M. M. , &amp; de Barros, A. L. B. L. (2018). Ineffective health management in people with heart failure: A pilot study. International Journal of Nursing Knowledge, 29(1), 11&#x2013;17. 10.1111/2047-3095.12142</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12142</ArticleId><ArticleId IdType="pubmed">27221327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti, A. C. D. , &amp; Pereira, J. D. M. V. (2014). Nursing diagnoses of patients with heart failure: An integrative review. Online Brazilian Journal of Nursing, 13(1), 113&#x2013;124.</Citation></Reference><Reference><Citation>Costa, M. B. , da Silva Bandeira, G. M. , Pereira, J. D. M. V. , da Silva Figueiredo, L. , Cordeiro, R. G. , Flores, P. V. P. , &amp; Cavalcanti, A. C. D. (2019). Association of international NANDA nursing diagnoses with hospitalization and death in heart failure. Nursing (S&#xe3;o Paulo), 22(250), 2783&#x2013;2787. 10.36489/nursing.2019v22i250p2783-2787</Citation><ArticleIdList><ArticleId IdType="doi">10.36489/nursing.2019v22i250p2783-2787</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa Galv&#xe3;o, P. C. , Gomes, E. T. , Figueir&#xea;do, T. R. , &amp; da Silva Bezerra, S. M. M. (2016). Diagnostics of disease&#x2010;inculate applied to patients with decompensated cardiac insuffici&#xea;ncia. Cogitare Enfermagem, 21(2), 1&#x2013;8.</Citation></Reference><Reference><Citation>da Silva Alves Souza, L. M. , Cotait Ayoub, A. , &amp; Ruiz Zimmer Cavalcante, A. M. (2017). Nursing diagnosis for people with heart failure based on the hemodynamic profiles. International Journal of Nursing Knowledge, 28(4), 199&#x2013;203. 10.1111/2047-3095.12151</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12151</ArticleId><ArticleId IdType="pubmed">27393577</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Correia, D. M. , Dantas Cavalcanti, A. C. , de Carvalho Queluci, G. , Ramos Brum, A. K. , de Melo Vellozo Pereira Tinoco, J. , &amp; Garcia Rosa, M. L. (2021). Consensus on the delphi method of priority nursing diagnosis for heart failure in primary care. Revista de Pesquisa: Cuidado e Fundamental, 13(1). 10.9789/2175-5361.rpcfo.v13.9687</Citation><ArticleIdList><ArticleId IdType="doi">10.9789/2175-5361.rpcfo.v13.9687</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang, D. , Dearholt, S. L. , Bissett, K. , Ascenzi, J. , &amp; Whalen, M. (2021). Johns Hopkins evidence&#x2010;based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau.</Citation></Reference><Reference><Citation>Dantas Cavalcanti, A. C. , Vellozo Pereira, J. D. M. , Maciel dos Santos, R. O. , Andrade Vieira, G. C. , Ferreira Santana, R. , da Silva Correia, D. M. , &amp; Queluci, G. D. C. (2013). Observational study of clinical validation of nursing diagnosis anxiety in patients with chronic heart failure. Global Nursing, 12(30), 28&#x2013;40.</Citation></Reference><Reference><Citation>de Almeida Neto, O. P. (2017). Diagn&#xf3;sticos de enfermagem de pacientes com insufici&#xea;ncia cardiaca com fra&#xe7;&#xe3;o de eje&#xe7;&#xe3;o reduzida. Rev Med Minas Gerais, 27, e&#x2013;1878. 10.5935/2238-3182.20170074</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/2238-3182.20170074</ArticleId></ArticleIdList></Reference><Reference><Citation>de Padua, B. L. R. , Vieira, G. C. A. , Pereira, J. D. M. V. , da Silva Figueiredo, L. , Flores, P. V. P. , &amp; Cavalcanti, A. C. D. (2019). Diagn&#xf3;stico de enfermagem intoler&#xe2;ncia &#xed; atividade em pacientes com insufici&#xea;ncia cardiac cr&#xf4;nica. Nursing (S&#xe3;o Paulo), 22(250), 2716&#x2013;2720. 10.36489/nursing.2019v22i250p2716-2720</Citation><ArticleIdList><ArticleId IdType="doi">10.36489/nursing.2019v22i250p2716-2720</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza Carneiro, C. , Takao Lopes, C. , de Lima Lopes, J. , Batista Santos, V. , Bachion, M. M. , &amp; de Barros, A. L. (2017). Conceptual and operational definitions of the defining characteristics and related factors of the diagnosis ineffective health management in people with heart failure. International Journal of Nursing Knowledge, 28(2), 76&#x2013;87. 10.1111/2047-3095.12124</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12124</ArticleId><ArticleId IdType="pubmed">26549691</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza, V. , Zeitoun, S. S. , Lopes, C. T. , de Oliveira, A. P. , de Lima Lopes, J. , &amp; de Barros, A. L. (2015). Clinical usefulness of the definitions for defining characteristics of activity intolerance, excess fluid volume and decreased cardiac output in decompensated heart failure: A descriptive exploratory study. Journal of Clinical Nursing, 24(17&#x2013;18), 2478&#x2013;2487. 10.1111/jocn.12832</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocn.12832</ArticleId><ArticleId IdType="pubmed">25959208</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos, E. R. , de Souza, M. F. , de Guti&#xe9;rrez, M. G. , Maria, V. L. , &amp; de Barros, A. L. (2013). Validation of the concept risk for decreased cardiac output. Revista Latino&#x2010;Americana de Enfermagem, 21, 97&#x2013;104. 10.1590/S0104-11692013000700013</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0104-11692013000700013</ArticleId><ArticleId IdType="pubmed">23459896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernandes, C. M. , Bernardes, D. S. , Mantovani, V. M. , Pedraza, L. L. , &amp; Rabelo&#x2010;Silva, E. R. (2019). Predi&#xe7;&#xe3;o de risco e acur&#xe1;cia diagn&#xf3;stica em pacientes internados com insufici&#xea;ncia cardiaca descompensada: estudo de coorte [Prediction of risk and diagnostic accuracy in patients hospitalized for decompensated heart failure: Cohort study]. Revista Gaucha de Enfermagem, 40, e20180032. 10.1590/1983-1447.2019.20180032</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1983-1447.2019.20180032</ArticleId><ArticleId IdType="pubmed">31188980</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmakis, D. , Parissis, J. , Lekakis, J. , &amp; Filippatos, G. (2015). Acute heart failure: Epidemiology, risk factors, and prevention. Revista Espa&#xf1;ola de Cardiologia (English ed.), 68(3), 245&#x2013;248. 10.1016/j.rec.2014.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2014.11.004</ArticleId><ArticleId IdType="pubmed">25659507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez, A. M. , &amp; Mena, R. P. (2022). Epidemiology and diagnosis of heart failure. FMC&#x2010;Continuing Medical Education in Primary Care, 29(6), 2&#x2013;15. 10.1016/j.fmc.2022.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fmc.2022.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenewegen, A. , Rutten, F. H. , Mosterd, A. , &amp; Hoes, A. W. (2020). Epidemiology of heart failure. European Journal of Heart Failure, 22(8), 1342&#x2013;1356. 10.1002/ejhf.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1858</ArticleId><ArticleId IdType="pmc">PMC7540043</ArticleId><ArticleId IdType="pubmed">32483830</ArticleId></ArticleIdList></Reference><Reference><Citation>

Harrer, M.
, 
Cuijpers, P.
, 
Furukawa, T.
, &amp; 
Ebert, D. D.
 (2019). 
dmetar: Companion R Package for the guide &#x2018;Doing Meta&#x2010;Analysis in R&#x2019;
. R package version 0.1.0. http://dmetar.protectlab.org/
</Citation></Reference><Reference><Citation>Harrer, M. , Cuijpers, P. , Furukawa, T. A. , &amp; Ebert, D. D. (2021). Doing meta&#x2010;analysis with R: A hands&#x2010;on guide. Chapman &amp; Hall/CRC Press.</Citation></Reference><Reference><Citation>Herdman, T. H. , &amp; Kamitsuru, S. (Eds.). (2018&#x2013;2020). NANDA International, Inc. nursing diagnoses: Definitions and classification 2018&#x2013;2020 (11th ed.). Elsevier Health Sciences, Thieme.</Citation></Reference><Reference><Citation>Herdman, T. H. , &amp; Kamitsuru, S. (Eds.). (2021&#x2013;2023). NANDA International, Inc. Nursing diagnoses: Definitions and classification 2021&#x2013;2023 (12th ed.). Elsevier Health Sciences, Thieme.</Citation></Reference><Reference><Citation>Higgins, J. P. , &amp; Thompson, S. G. (2002). Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine, 21(11), 1539&#x2013;1558. 10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill, M. A. , Jaisser, F. , &amp; Sowers, J. R. (2022). Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness. Cardiovasc Res, 118(1), 130&#x2013;140. 10.1093/cvr/cvaa326</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa326</ArticleId><ArticleId IdType="pmc">PMC8752352</ArticleId><ArticleId IdType="pubmed">33188592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunney, M. (2013). Critical thinking to achieve positive health outcomes: Nursing case studies and analyses (2nd ed.). John Wiley &amp; Sons.</Citation></Reference><Reference><Citation>Mart&#xed;nez Santos, P. , Bover Freire, R. , Esteban Fern&#xe1;ndez, A. , Bernal Sobrino, J. L. , Fern&#xe1;ndez P&#xe9;rez, C. , Elola Somoza, F. J. , Macaya Miguel, C. , &amp; Vilacosta, I. (2019). In&#x2010;hospital Mortality and Readmissions for Heart Failure in Spain. A study of index episodes and 30&#x2010;day and 1&#x2010;year cardiac readmissions. Revista Espa&#xf1;ola de Cardiologia (English ed.), 72(12), 998&#x2013;1004. 10.1016/j.rec.2019.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2019.02.004</ArticleId><ArticleId IdType="pubmed">30930253</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh, T. A. , Metra, M. , Adamo, M. , Gardner, R. S. , Baumbach, A. , B&#xf6;hm, M. , &amp; Kathrine Skibelund, A. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 24(1), 4&#x2013;131. 10.1002/ejhf.2333</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2333</ArticleId><ArticleId IdType="pubmed">35083827</ArticleId></ArticleIdList></Reference><Reference><Citation>MDConagh, T. A. , Metra, M. , Adamo, M. , Gardner, R. S. , Baumbach, A. , B&#xf6;hm, M. , &amp; Kathrine Skibelund, A. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 24(1), 4&#x2013;131. 10.1002/EJHF.2333</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/EJHF.2333</ArticleId><ArticleId IdType="pubmed">35083827</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento, M. N. R. , Vieira, N. R. , Aguiar, C. A. D. S. , Coelho, M. E. A. A. , F&#xe9;lix, N. D. D. C. , &amp; Oliveira, C. J. D. (2019). Aspects of nursing assistance for the person with heart failure. Revista de Enfermagem e Aten&#xe7;&#xe3;o &#xe0; Sa&#xfa;de, 8(2), 123&#x2013;134. 10.18554/reas.v8i2.3899</Citation><ArticleIdList><ArticleId IdType="doi">10.18554/reas.v8i2.3899</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira, A. P. D. , Cavalcante, A. M. R. Z. , Carneiro, C. S. , Santos, V. B. , Moorhead, S. , Lopes, J. L. , &amp; Barros, A. L. B. L. (2020). Health education: The effectiveness of interventions in patients with heart failure. Revista Brasileira de Enfermagem, 73(2), e20180782. 10.1590/0034-7167-2018-0782</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0034-7167-2018-0782</ArticleId><ArticleId IdType="pubmed">32159695</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M. J. , McKenzie, J. E. , Bossuyt, P. M. , Boutron, I. , Hoffmann, T. C. , Mulrow, C. D. , Shamseer, L. , Tetzlaff, J. M. , Akl, E. A. , Brennan, S. E. , Chou, R. , Glanville, J. , Grimshaw, J. M. , Hr&#xf3;bjartsson, A. , Lalu, M. M. , Li, T. , Loder, E. W. , Mayo&#x2010;Wilson, E. , MDConald, S. , &#x2026; Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PRISMA 2020 Statement: An updated guide for the publication of systematic reviews. Revista Espa&#xf1;ola de Cardiologia (English ed.), 74(9), 790&#x2013;799. 10.1016/j.rec.2021.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2021.07.010</ArticleId><ArticleId IdType="pubmed">34446261</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, H. , &amp; Tucker, D. A. (2017). Capturing key NANDA&#x2010;I nursing diagnoses from actual clinical data for patients with heart failure. International Journal of Nursing Knowledge, 28(1), 30&#x2013;36. 10.1111/2047-3095.12097</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12097</ArticleId><ArticleId IdType="pubmed">26011168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira, J. M. , Cavalcanti, A. C. , Lopes, M. V. , da Silva, V. G. , de Souza, R. O. , &amp; Gon&#xe7;alves, L. C. (2015). Accuracy in inference of nursing diagnoses in heart failure patients. Revista Brasileira de Enfermagem, 68(4), 603&#x2013;696. 10.1590/0034-7167.2015680417i</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0034-7167.2015680417i</ArticleId><ArticleId IdType="pubmed">26422042</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira, J. M. , Flores, P. V. , Figueiredo, L. D. , Arruda, C. S. , Cassiano, K. M. , Vieira, G. C. , Guerra, T. R. , Silva, V. A. , &amp; Cavalcanti, A. C. (2016). Nursing diagnoses of hospitalized patients with heart failure: A longitudinal study. Revista da Escola de Enfermagem da USP, 50(6), 929&#x2013;936. 10.1590/S0080-623420160000700008</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0080-623420160000700008</ArticleId><ArticleId IdType="pubmed">28198957</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, J. L. , Sutton, A. J. , Jones, D. R. , Abrams, K. R. , &amp; Rushton, L. (2008). Contour&#x2010;enhanced meta&#x2010;analysis funnel plots help distinguish publication bias from other causes of asymmetry. Journal of Clinical Epidemiology, 61(10), 991&#x2013;996. 10.1016/j.jclinepi.2007.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.010</ArticleId><ArticleId IdType="pubmed">18538991</ArticleId></ArticleIdList></Reference><Reference><Citation>
R Core Team. (2013). A: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R&#x2010;project.org/
</Citation></Reference><Reference><Citation>Rojas S&#xe1;nchez, L. Z. , Hern&#xe1;ndez Vargas, J. A. , Trujillo C&#xe1;ceres, S. J. , Roa D&#xed;az, Z. M. , Jurado Arenales, A. M. , &amp; Toloza P&#xe9;rez, Y. G. (2017). Usefulness of the diagnosis &#x201c;Decreased Cardiac Output (00029)&#x201d; in patients with chronic heart failure. International Journal of Nursing Knowledge, 28(4), 192&#x2013;198. 10.1111/2047-3095.12148</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12148</ArticleId><ArticleId IdType="pubmed">27245262</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos, V. B. , Lopes, C. T. , Dos Anjos, L. D. , Begot, I. , Cassiolatto, F. , Guizilinni, S. , &amp; Moreira, R. S. L. (2020). Accuracy of the defining characteristics of fatigue in patients with heart failure as identified by the 6&#x2010;minute walking test. International Journal of Nursing Knowledge, 31(3), 188&#x2013;193. 10.1111/2047-3095.12270</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2047-3095.12270</ArticleId><ArticleId IdType="pubmed">31891224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer, G. , Chemaitelly, H. , Abu&#x2010;Raddad, L. J. , &amp; R&#xfc;cker, G. (2019). Seriously misleading results using inverse of Freeman&#x2010;Tukey double arcsine transformation in meta&#x2010;analysis of single proportions. Research Synthesis Methods, 10(3), 476&#x2013;483. 10.1002/jrsm.1348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1348</ArticleId><ArticleId IdType="pmc">PMC6767151</ArticleId><ArticleId IdType="pubmed">30945438</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, C. , Ara&#xfa;jo, S. , Morais, S. , &amp; Fraz&#xe3;o, C. (2021). Impaired knowledge in individuals with heart failure: A middle range nursing theory. Revista Brasileira de Enfermagem, 75(2), e20200855. 10.1590/0034-7167-2020-0855</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0034-7167-2020-0855</ArticleId><ArticleId IdType="pubmed">34669899</ArticleId></ArticleIdList></Reference><Reference><Citation>Stijnen, T. , Hamza, T. H. , &amp; Ozdemir, P. (2010). Random effects meta&#x2010;analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Statistics in Medicine, 29(29), 3046&#x2013;3067. 10.1002/sim.4040</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4040</ArticleId><ArticleId IdType="pubmed">20827667</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, C. , Zhang, J. , Rong, J. , Ma, W. , &amp; Yang, H. (2023). Impact of nurse&#x2010;led education on the prognosis of heart failure patients: A systematic review and meta&#x2010;analysis. International Nursing Review, 71(1), 180&#x2013;188. Published online. 10.1111/inr.12852</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/inr.12852</ArticleId><ArticleId IdType="pubmed">37335580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinoco, J. M. V. P. , Figueiredo, L. D. S. , Flores, P. V. P. , Padua, B. L. R. , Mesquita, E. T. , &amp; Cavalcanti, A. C. D. (2021). Effectiveness of health education in the self&#x2010;care and adherence of patients with heart failure: A meta&#x2010;analysis. Revista Latino&#x2010;Americana de Enfermagem, 29, e3389. 10.1590/1518.8345.4281.3389</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1518.8345.4281.3389</ArticleId><ArticleId IdType="pmc">PMC8294794</ArticleId><ArticleId IdType="pubmed">34287537</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojahn, M. M. , Barilli, S. L. S. , Bernardes, D. D. S. , Pedraza, L. L. , Aliti, G. B. , &amp; Rabelo&#x2010;Silva, E. R. (2020). B&#x2010;type natriuretic peptide levels and diagnostic accuracy: excess fluid volume. Revista Gaucha de Enfermagem, 41(spe), e20190095. 10.1590/1983-1447.2020.20190095</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1983-1447.2020.20190095</ArticleId><ArticleId IdType="pubmed">32294683</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianna, T. A. , da Silva, K. C. F. , da Cunha, A. L. , da Silva, M. R. B. , Chicharo, S. C. R. , &amp; da Silva Duarte, A. C. (2021). Heart failure and as principalis defining characteristics do diagnosis of excessive fluid volume disease. Sa&#xfa;de Coletiva (Barueri), 11(62), 5260&#x2013;5271. 10.36489/saudecoletiva.2021v11i62p5260-5271</Citation><ArticleIdList><ArticleId IdType="doi">10.36489/saudecoletiva.2021v11i62p5260-5271</ArticleId></ArticleIdList></Reference><Reference><Citation>

Viechtbauer, W.
 (2010). Conducting meta&#x2010;analyses in R with the metafor package. Journal of Statistical Software, 36(3), 1&#x2013;48. http://www.jstatsoft.org/v36/i03/
</Citation></Reference><Reference><Citation>Viechtbauer, W. , &amp; Cheung, M. W. (2010). Outlier and influence diagnostics for meta&#x2010;analysis. Research Synthesis Methods, 1(2), 112&#x2013;125. 10.1002/jrsm.11</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.11</ArticleId><ArticleId IdType="pubmed">26061377</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>